The average hourly worker spends about $1,800 a year out of pocket on prescriptions. Unaffordable medications lead to non-adherence, condition escalation, and the workers’ compensation claims that follow.

There is a cost on your books you almost certainly are not tracking. It does not show up as a line item, it never crosses your desk for approval, and it grows quietly every year. It is the cost of your hourly workers not being able to afford the medications they have already been prescribed.

This is not a fringe problem. About one in five U.S. adults skips filling a prescription because of cost at least once a year, and one in three takes steps to stretch their medication, such as splitting pills or skipping doses, according to KFF. For salaried staff with deeper savings, that is an inconvenience. For an hourly worker living close to the edge of each paycheck, it is a monthly decision between a refill and the grocery bill. The medication loses.

What follows from that decision is the part most employers never connect back to the pharmacy counter: a slow escalation of untreated conditions that surfaces later as absenteeism, lost productivity, and more expensive workers’ compensation claims. Here is how the chain works, and what it is costing you.

Put a real number on it

For an hourly worker managing an ongoing condition, or filling regular prescriptions for a family, out-of-pocket drug costs can run about $1,800 a year. That figure is not abstract.

The average single-coverage deductible in employer health plans is now $1,886, according to KFF’s 2025 survey. Until a worker meets it, they often pay full price for their medications. Americans spent $98 billion out of pocket on prescriptions in 2024, a 25 percent jump over five years, per IQVIA. And brand-name and specialty drugs, which increasingly treat common conditions like diabetes and autoimmune disease, routinely cost $2,000 a month or more before any coverage applies.

Now layer that onto an hourly wage. A worker earning $18 an hour brings home roughly $2,500 a month after taxes. An $1,800 annual drug bill is most of a month’s take-home pay. When the choice is rent or refill, the prescription is what gets rationed. IQVIA found that more than a quarter of new prescriptions in 2024 were never filled at all.

This is also where the benefits gap compounds. Lower-wage workers already receive a smaller employer contribution toward their coverage and carry a larger share of the premium themselves. The people least able to absorb drug costs are the ones absorbing the most of them.

What happens when the medication gets skipped

Untreated conditions do not stay still. They escalate.

When a worker stops taking blood pressure medication, the hypertension does not pause politely until payday. When diabetes medication gets rationed, blood sugar climbs and complications follow. Cost-related non-adherence is consistently linked to worse outcomes, more emergency visits, and more hospitalizations. Medication non-adherence is estimated to drive between $100 billion and $300 billion in avoidable U.S. healthcare costs every year, contribute to roughly 100,000 preventable deaths, and account for as many as one in four hospitalizations.

For an employer, that escalation is not just a human tragedy. It is a workforce of people whose manageable conditions are quietly becoming unmanageable on your watch, and whose health plan claims and absences will reflect it.

The productivity bill lands on your P&L

Long before a condition lands someone in the hospital, it is eroding their output every shift.

The research here is unusually direct. Employees who stay adherent to their medications take up to seven fewer days off work than those who do not. For a single condition like asthma or COPD, adherence has been associated with around $2,500 per employee per year in avoided absenteeism costs. Across the whole economy, absenteeism and presenteeism, which is showing up but working while sick or impaired, cost U.S. employers upward of $500 billion a year, according to RAND.

Presenteeism is the part most managers underestimate. The worker with untreated hypertension or unmanaged depression is at their station, but slower, more error-prone, and more likely to get hurt. They are on the clock and off their game, and there is no absence report to flag it. Health-related productivity losses have been estimated at more than twice the size of the direct medical costs employers already see. The visible bill is the smaller one.

The straight line from the pharmacy counter to the workers’ comp claim

This is where it stops being a benefits issue and becomes a risk-and-cost issue, and it is the part that should get a CFO’s attention.

When an hourly worker with an unmanaged chronic condition gets injured on the job, that condition does not sit out the claim. It becomes a comorbidity, and comorbidities make workers’ compensation claims dramatically more expensive and slower to close.

A 2025 study from the Workers Compensation Research Institute, analyzing more than 930,000 lost-time claims across 32 states, found that claims involving comorbidities such as hypertension, diabetes, obesity, mental health conditions, and substance use carry higher medical and indemnity costs and longer temporary disability durations than claims without them. WCRI has also found that a comorbidity increases the likelihood a claim becomes complex by about a third. In one industry survey, 63 percent of professionals named comorbidities the single biggest barrier to an injured worker’s recovery.

The timing matters too. NCCI reports that while claim frequency is falling, the claims that do happen are getting more severe, with both medical and indemnity severity up around 6 percent in the latest year and the average number of lost workdays climbing past 80 days. A workforce carrying unmanaged chronic conditions is a workforce primed to turn an ordinary sprain into a long, complicated, expensive claim.

So the worker who could not afford their $40 blood pressure refill in March becomes the worker whose back injury in September takes 30 extra days to heal and costs thousands more to resolve. That is the same dollar problem, just measured at a much later and much more expensive stage.

Where this hits hardest

The sectors that lean on hourly labor are the same ones where physical demands and chronic-condition prevalence collide.

In manufacturing and logistics, the work is hard on the body, and an aging hourly workforce often carries hypertension, diabetes, and joint conditions into physically demanding roles. In retail, heavy part-time staffing means many workers have little or no access to affordable coverage in the first place, so non-adherence starts early. In healthcare, the people delivering care frequently cannot afford their own, with lower-paid clinical and support staff facing the same affordability squeeze as hourly workers anywhere. In every one of these, an unaffordable prescription today is a more expensive injury tomorrow.

What employers can actually do about it

The fix is not simply paying for more drug coverage and hoping adherence improves. It is closing the gap between a prescription being written and a worker actually being able to use it, affordably and without losing a shift to do so.

The employers getting ahead of this are doing a few things differently:

• Removing cost barriers on the medications that matter most. Value-based plan designs that make maintenance drugs for chronic conditions low-cost or free protect both the worker and the long-term claim. A $0 copay on hypertension medication is cheaper than the stroke, the hospitalization, or the comorbid claim it prevents.
• Bringing care and medication management to the worksite. On-site and near-site clinics let hourly workers get screened, treated, and refilled without taking unpaid time off, which is the single biggest reason frontline workers skip care. Care that meets the worker where they already are gets used.
• Catching conditions early. The WCRI research points to the same conclusion every time: early identification and intervention is what keeps a comorbidity from quietly driving up a future claim. On-site health screening turns an undiagnosed condition into a managed one before it ever touches a workers’ comp file.
• Pairing it with financial breathing room. Tools like earned wage access and financial wellness support address the paycheck-to-paycheck reality that drives rationing in the first place.

This is the core of what integrated specialty care is built to do. Across the HealthcareLive network of more than 500 employers and 4.5 million lives, the model is the same one the claims research keeps pointing to: identify the condition early, treat the whole worker on site rather than sending them into the most expensive corner of the system, and manage recovery so a routine injury stays routine. Managing an injury through on-site, integrated care averages about $482, against roughly $2,800 when that same injury starts in the emergency room. The chronic-condition management that happens alongside it is what keeps the next claim from being a complex one.

The bottom line

An unaffordable prescription is rarely just a benefits inconvenience. It is the first link in a chain that runs through non-adherence, condition escalation, lost productivity, and ultimately the workers’ compensation claims that cost the most and last the longest. The good news is that the chain is interruptible, and the earliest link is also the cheapest one to fix.

If your hourly turnover is high, your absenteeism is creeping up, or your workers’ comp claims keep coming in more complex than the injuries seem to warrant, the place to look is upstream, at whether your workforce can actually afford and access the care they have already been prescribed.

Find out what it’s costing you. Request a workforce health review built on your industry, headcount, and claims history, and we will show you where unmanaged conditions are quietly driving your productivity and claim costs, and what it would take to close the gap.

Frequently asked questions

How much do hourly workers spend out of pocket on prescriptions? An hourly worker who manages an ongoing condition or fills regular prescriptions for a family can spend roughly $1,800 a year out of pocket, driven largely by deductibles that average $1,886 for single coverage and the high cost of brand and specialty drugs before coverage applies.

How common is skipping medication because of cost? About one in five U.S. adults skips filling a prescription because of cost at least once a year, and one in three takes cost-cutting steps such as splitting pills or skipping doses. Lower-wage workers are affected at higher rates.

How does medication non-adherence affect productivity? Workers who stay adherent take up to seven fewer days off than those who do not, and unmanaged conditions reduce on-the-job performance even when workers show up. Absenteeism and presenteeism together cost U.S. employers an estimated $500 billion or more a year.

What is the connection between prescriptions and workers’ compensation costs? Unmanaged chronic conditions become comorbidities that raise the cost and duration of workers’ compensation claims. Research from WCRI shows claims involving conditions like diabetes, hypertension, and obesity cost more and take longer to resolve, and comorbidities raise the odds a claim becomes complex by about a third.

What can employers do to improve medication affordability and adherence? Lower or eliminate cost-sharing on chronic-condition maintenance drugs, bring screening and care on site so workers do not lose pay to get treated, identify conditions early, and pair health benefits with financial-stability support.

Sources

This article reflects the most recent data available as of June 2026.

• KFF, 2025 Employer Health Benefits Survey and KFF prescription affordability polling. Average single-coverage deductible ($1,886); roughly one in five adults skip filling a prescription due to cost, and one in three use cost-cutting strategies.
• IQVIA, The Use of Medicines in the U.S. (2024 data). Out-of-pocket prescription spending of $98 billion in 2024, up 25 percent over five years; more than one-quarter of new prescriptions left unfilled.
• Peer-reviewed and federal research on medication non-adherence. Estimated $100 billion to $300 billion in avoidable U.S. healthcare costs annually, roughly 100,000 preventable deaths, and up to one in four hospitalizations linked to non-adherence; adherent employees take up to seven fewer days off work.
• RAND Corporation (2025). Absenteeism and presenteeism cost U.S. employers upward of $500 billion annually in lost productivity.
• Workers Compensation Research Institute, Degenerative and Comorbid Conditions in Workers’ Compensation (March 2025). Analysis of more than 930,000 lost-time claims across 32 states showing comorbidities raise claim costs and temporary disability duration; comorbidities increase the likelihood of a complex claim by about a third.
• NCCI (2024 to 2025 results). Medical and indemnity claim severity up about 6 percent; average lost workdays climbing past 80 days.
• HealthcareLive network data. On-site and integrated specialty care cost averages across 500-plus employer partners and 4.5 million lives.

This report is informational and is not insurance, medical, legal, or financial advice. Figures attributed to public sources reflect those organizations’ most recent published data; network figures are HealthcareLive averages and may differ from your results.